Abstract |
Metastatic disease caused by castration-resistant prostate cancer (CRPC) is the principal cause of prostate cancer (PCa)-related mortality. CRPC occurs within 2-3 years of initiation of androgen deprivation therapy (ADT), which is an important factor of influencing PCa metastasis. Recent studies have revealed that non-coding RNAs in PCa can enhance metastasis and progression, while the mechanisms are still unclear. In this study, we reported that the long noncoding RNA-LINC00963 was increased in CRPC tissues and promoted migration of PCa cells in vitro and their metastasis in vivo. High levels of LINC00963 significantly decreased tumor suppressor miR-542-3p, whose levels in metastasis tissues were low compared to those in non- metastasis tissues. LINC00963 promotes and miR-542-3p inhibits metastasis. Furthermore, the expression levels of LINC00963 and miR-542-3p were positively and negatively associated with the expression of NOP2. We demonstrated that NOP2 promoted PCa by activating the epithelial-mesenchymal transition (EMT) pathway. For specific mechanism, dual luciferase reporter assays showed that miR-542-3p directly binds to both 3'-untranslated region (UTR) of LINC00963 and NOP2 mRNA. Taken together, our results show that LINC00963 acts as an inducer of PCa metastasis by binding miR-542-3p, thereby promoting NOP2. This axis may have diagnostic and therapeutic potential for advanced PCa.
|
Authors | Feng Sun, Ke Wu, Zhixian Yao, Xingyu Mu, Zhong Zheng, Menghao Sun, Yong Wang, Zhihong Liu, Yiyong Zhu |
Journal | Aging
(Aging (Albany NY))
Vol. 12
Issue 12
Pg. 11500-11516
(06 17 2020)
ISSN: 1945-4589 [Electronic] United States |
PMID | 32554858
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- MIRN542 microRNA, human
- MIRN542 microRNA, mouse
- MicroRNAs
- Nuclear Proteins
- RNA, Long Noncoding
- long non-coding RNA LINC00963, human
- NOP2 protein, human
- Nop2 protein, mouse
- Protein Methyltransferases
- tRNA Methyltransferases
|
Topics |
- Animals
- Cell Line, Tumor
- Disease Models, Animal
- Epithelial-Mesenchymal Transition
(genetics)
- Gene Expression Regulation, Neoplastic
- Gene Knockdown Techniques
- Humans
- Male
- Mice
- Mice, Transgenic
- MicroRNAs
(agonists, antagonists & inhibitors, metabolism)
- Neoplasm Metastasis
(genetics)
- Nuclear Proteins
(genetics)
- Prostate
(pathology)
- Prostatic Neoplasms, Castration-Resistant
(genetics, pathology)
- Protein Methyltransferases
(genetics)
- RNA, Long Noncoding
(genetics, metabolism)
- RNA-Seq
- Xenograft Model Antitumor Assays
- tRNA Methyltransferases
(genetics)
|